Clinical Trial Update: A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

View source ↗

Summary

This completed clinical trial evaluated the clinical course, outcomes, and risk factors of myocarditis and pericarditis after vaccination with the Moderna COVID…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocarditis
• Pericarditis

Drugs mentioned

• Moderna COVID-19 vaccine (SARS-CoV-2 vaccine, mRNA-1273)

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Myocarditis, Pericarditis | Status: COMPLETED